Outcome of Board meeting held on May 30, 2025, w.r.t approval of Audited Financial Results for the quarter and year ended March 31, 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The Board of Kothari Fermentation & Biochem approved audited standalone financial results for Q4 FY25 and the full year ended March 31, 2025, with an unmodified (clean) audit opinion from Kothari Kuldeep & Co. Revenue from operations grew to Rs. 11,423.10 lakhs in FY25 from Rs. 10,888.09 lakhs in FY24, up about 4.9%. The company reported a major turnaround — net profit of Rs. 50.99 lakhs in FY25 versus a loss of Rs. 491.15 lakhs in FY24 — while Q4 FY25 PAT rose to Rs. 105.13 lakhs from Rs. 86.96 lakhs. EPS swung to Rs. 0.54 from a loss of Rs. 3.27. Operating cash flow was healthy at Rs. 1,070.32 lakhs (vs Rs. 863.24 lakhs prior year), and total borrowings declined. Business continues to operate in a single segment (Yeast), with a cattle feed extension noted.
Positive for shareholders — the company swung from a net loss to a small profit, posted positive operating cash flow, reduced debt, and secured a clean audit. While FY revenue growth was modest, the bottom-line turnaround and stable operations should support sentiment, though the absolute profit remains thin relative to revenue.